EPS growth is an important number as it indicates the future prospects of NanoVibronix. The EPS growth rate, as it is usually called, is typically displayed as a percentage, which at this time is hard to estimate, but revenue growth has been 26.10 % over the last twelve months. Growth in EPS is an important measure of administration performance because it shows how much money NanoVibronix is making for it’s investors or shareholders.



NanoVibronix trades as part of the medical devices industry and is in the healthcare sector. The company CEO is Brian M. Murphy. NanoVibronix Inc designs noninvasive biological response-activating devices which target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.

Previous Intraday Performance:

The NAOV shares had a previous change of -1.50% which opened at 3.97 and closed at 3.95. It moved to an intraday high of 4.00 and a low of 3.65.

SeekingAlpha:  NanoVibronix reports Q2 results

Historical Performance:

Over the last five trading days, NAOV shares returned -1.25% and in the past 30 trading days it returned -8.14%. Over three months, it changed -14.13%. In one year it has changed -12.30% and within that year its 52-week high was 5.00 and its 52-week low was 3.57. NAOV stock is 10.64% above its 52 Week Low.

Our calculations result in a 200 day moving average of 4.55 and a 50 day moving average of 4.36. Right now, NAOV stock is trading -13.14% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

SeekingAlpha:  NanoVibronix reports Q2 results

Liquidity:

The company has a market cap of $15.6m with 4.0m shares outstanding and a float of 4.0m shares. Trading volume was 9,996 shares and has experienced an average volume of 3,638 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for NanoVibronix was -0.98 which ended on 31st of December 2017.

Below was the last reported quarterly earnings per share:
06-30-2018:  0.00 (estimated)
03-31-2018:  0
12-31-2017:  0
09-30-2017:  -0.35



Indicators Also to Watch:

Based on the latest filings, there is 27.70% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.

I calculated the beta to be 0.01

SeekingAlpha:  Six Flags’ Earnings Was A Surprise – Cramer’s Lightning Round (10/29/18)

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is 1,363.83%, return on assets is -289.77%, price-to-sales is 56.89 and price-to-book is 8.48.

Company Score Card:

Results are out of six:
 3  : Growth Expectations Result
 6  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here